Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
15 participants
INTERVENTIONAL
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Artelon MTP Spacer
Metatarsophalageal hemi-implant
Artelon MTP Spacer
Metatarsophalangeal hemi-implant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Artelon MTP Spacer
Metatarsophalangeal hemi-implant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient has a clinically and radiographically verified arthritis in the MTP-I joint indicating the need for surgical treatment.
* The patient reads, understands and is able to complete the study questionnaires in Swedish.
* The patient has received written and oral information regarding the study and has signed the informed consent form.
Exclusion Criteria
* The patient has previously received surgical treatment affecting the anatomy of the MTP-I joint.
* The patient has a systemic rheumatic disease, ongoing infection, hallux valgus or is seriously ill.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Artimplant AB
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Artimplant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Alund, M.D.
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska University Hospital, Mölndal, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sahlgrenska Universitetssjukhuset, Område Ortopedi, Mölndal
Mölndal, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KP026
Identifier Type: -
Identifier Source: org_study_id